← FTC press releases
Consent Order Resolves Charges That Biovail and Elan Agreement Unreasonably Restrained Competition In Market for Generic Anti-hypertension Drug
other
· 2002-06-01
Source
Authoritative
FTC press release
Machine
JSON-LD
·
Markdown